Report Detail
Global Follow-on Biologics Market Insights, Forecast to 2025
- RnM2923659 |
- 11 February, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The global Follow-on Biologics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Follow-on Biologics market based on company, product type, end user and key regions.
This report studies the global market size of Follow-on Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Follow-on Biologics in these regions.
This research report categorizes the global Follow-on Biologics market by top players/brands, region, type and end user. This report also studies the global Follow-on Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
Market size by Product
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
Market size by End User
Oncology
Blood Disorders
Chronic Diseases
Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Follow-on Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Follow-on Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Follow-on Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Follow-on Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Follow-on Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Follow-on Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Follow-on Biologics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Follow-on Biologics Market Size Growth Rate by Product
- 1.4.2 Recombinant Non-glycosylated Proteins
- 1.4.3 Recombinant Glycosylated Proteins
- 1.4.4 Recombinant Peptides
- 1.5 Market by End User
- 1.5.1 Global Follow-on Biologics Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Blood Disorders
- 1.5.4 Chronic Diseases
- 1.5.5 Autoimmune Diseases
- 1.5.6 Growth Hormone Deficiency
- 1.5.7 Infectious Diseases
- 1.5.8 Other Diseases
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Follow-on Biologics Market Size
- 2.1.1 Global Follow-on Biologics Revenue 2014-2025
- 2.1.2 Global Follow-on Biologics Sales 2014-2025
- 2.2 Follow-on Biologics Growth Rate by Regions
- 2.2.1 Global Follow-on Biologics Sales by Regions
- 2.2.2 Global Follow-on Biologics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Follow-on Biologics Sales by Manufacturers
- 3.1.1 Follow-on Biologics Sales by Manufacturers
- 3.1.2 Follow-on Biologics Sales Market Share by Manufacturers
- 3.1.3 Global Follow-on Biologics Market Concentration Ratio (CR5 and HHI)
- 3.2 Follow-on Biologics Revenue by Manufacturers
- 3.2.1 Follow-on Biologics Revenue by Manufacturers (2014-2019)
- 3.2.2 Follow-on Biologics Revenue Share by Manufacturers (2014-2019)
- 3.3 Follow-on Biologics Price by Manufacturers
- 3.4 Follow-on Biologics Manufacturing Base Distribution, Product Types
- 3.4.1 Follow-on Biologics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Follow-on Biologics Product Type
- 3.4.3 Date of International Manufacturers Enter into Follow-on Biologics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Follow-on Biologics Sales by Product
- 4.2 Global Follow-on Biologics Revenue by Product
- 4.3 Follow-on Biologics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Follow-on Biologics Breakdown Data by End User
6 North America
- 6.1 North America Follow-on Biologics by Countries
- 6.1.1 North America Follow-on Biologics Sales by Countries
- 6.1.2 North America Follow-on Biologics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Follow-on Biologics by Product
- 6.3 North America Follow-on Biologics by End User
7 Europe
- 7.1 Europe Follow-on Biologics by Countries
- 7.1.1 Europe Follow-on Biologics Sales by Countries
- 7.1.2 Europe Follow-on Biologics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Follow-on Biologics by Product
- 7.3 Europe Follow-on Biologics by End User
8 Asia Pacific
- 8.1 Asia Pacific Follow-on Biologics by Countries
- 8.1.1 Asia Pacific Follow-on Biologics Sales by Countries
- 8.1.2 Asia Pacific Follow-on Biologics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Follow-on Biologics by Product
- 8.3 Asia Pacific Follow-on Biologics by End User
9 Central & South America
- 9.1 Central & South America Follow-on Biologics by Countries
- 9.1.1 Central & South America Follow-on Biologics Sales by Countries
- 9.1.2 Central & South America Follow-on Biologics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Follow-on Biologics by Product
- 9.3 Central & South America Follow-on Biologics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Follow-on Biologics by Countries
- 10.1.1 Middle East and Africa Follow-on Biologics Sales by Countries
- 10.1.2 Middle East and Africa Follow-on Biologics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Follow-on Biologics by Product
- 10.3 Middle East and Africa Follow-on Biologics by End User
11 Company Profiles
- 11.1 Sandoz
- 11.1.1 Sandoz Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sandoz Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sandoz Follow-on Biologics Products Offered
- 11.1.5 Sandoz Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Follow-on Biologics Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Teva Pahrmaceutical
- 11.3.1 Teva Pahrmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Pahrmaceutical Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Pahrmaceutical Follow-on Biologics Products Offered
- 11.3.5 Teva Pahrmaceutical Recent Development
- 11.4 Celltrion
- 11.4.1 Celltrion Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Celltrion Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Celltrion Follow-on Biologics Products Offered
- 11.4.5 Celltrion Recent Development
- 11.5 Biocon
- 11.5.1 Biocon Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Biocon Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Biocon Follow-on Biologics Products Offered
- 11.5.5 Biocon Recent Development
- 11.6 Amgen
- 11.6.1 Amgen Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Amgen Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Amgen Follow-on Biologics Products Offered
- 11.6.5 Amgen Recent Development
- 11.7 Samsung Biologics
- 11.7.1 Samsung Biologics Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Samsung Biologics Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Samsung Biologics Follow-on Biologics Products Offered
- 11.7.5 Samsung Biologics Recent Development
- 11.8 Mylan
- 11.8.1 Mylan Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Mylan Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Mylan Follow-on Biologics Products Offered
- 11.8.5 Mylan Recent Development
- 11.9 Dr. Reddy's Laboratories
- 11.9.1 Dr. Reddy's Laboratories Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Dr. Reddy's Laboratories Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Dr. Reddy's Laboratories Follow-on Biologics Products Offered
- 11.9.5 Dr. Reddy's Laboratories Recent Development
- 11.10 Stada Arzneimittel AG
- 11.10.1 Stada Arzneimittel AG Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Stada Arzneimittel AG Follow-on Biologics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Stada Arzneimittel AG Follow-on Biologics Products Offered
- 11.10.5 Stada Arzneimittel AG Recent Development
12 Future Forecast
- 12.1 Follow-on Biologics Market Forecast by Regions
- 12.1.1 Global Follow-on Biologics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Follow-on Biologics Revenue Forecast by Regions 2019-2025
- 12.2 Follow-on Biologics Market Forecast by Product
- 12.2.1 Global Follow-on Biologics Sales Forecast by Product 2019-2025
- 12.2.2 Global Follow-on Biologics Revenue Forecast by Product 2019-2025
- 12.3 Follow-on Biologics Market Forecast by End User
- 12.4 North America Follow-on Biologics Forecast
- 12.5 Europe Follow-on Biologics Forecast
- 12.6 Asia Pacific Follow-on Biologics Forecast
- 12.7 Central & South America Follow-on Biologics Forecast
- 12.8 Middle East and Africa Follow-on Biologics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Follow-on Biologics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Follow-on Biologics . Industry analysis & Market Report on Follow-on Biologics is a syndicated market report, published as Global Follow-on Biologics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Follow-on Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
